Archive for category: Research news

Can we Prevent and Cure Alzheimer’s Disease?

/in , , , , , /by

The fantastic speaker sessions from our first Open Research event are now available to watch on our YouTube channel

Read more

Join us at our Open Research Evening – “Can We Prevent and Cure Alzheimer’s Disease?”

/in , , , , , , /by

We are very excited to be hosting an Open Research Evening – “Can We Prevent and Cure Alzheimer’s Disease?” …

Read more

SBS webinar event for GPs in Scotland

/in , , , , , , /by

We hope to create a proactive Scottish network of GPs who want to help their patients become more aware of their current and future brain health.

Read more

Brain Health Life Science Summit at St Andrews

/in , , , , /by

On 10th May, some of our SBS team headed to the St Andrews Eden Campus to attend the Brain Health Life Science Summit. Read more…

Read more

Professor Craig Ritchie: hope for the future in dementia research

/in , , , , , /by

Read here for an insight from the STV News show, Scotland Tonight, with our CEO and Founder, Prof Craig Ritchie, about the lifechanging potential for research to help detect Alzheimer’s early & treat before it progresses to dementia.

Read more

The SBS Blog – Welcome our new Chief Investigator!

/in , , , , /by

Please join us in welcoming Dr Sarah Gregory to the SBS Team as IONA National Coordinator! Read more about what she brings to Scottish Brain Sciences…

Read more

The SBS Blog – Welcome our new Senior Clinical Investigator!

/in , , , /by

We are thrilled to be able to welcome Dr Clara Russell to the SBS Team as Senior Clinical Investigator! Read more about what she brings to Scottish Brain Sciences…

Read more

Partnership seeks early Alzheimer’s blood test

/0 Comments/in , , /by

An agreement between Scottish Brain Sciences and a global leader in precision diagnostics is aiming to transform the ability of clinicians to identify the very earliest signs of Alzheimer’s Disease – long before symptoms can be seen.

Read more

Donanemab marks start of “new story” in Alzheimer’s research

/0 Comments/in , , , /by

Professor Craig Ritchie has told an international Alzheimer’s conference that phase 3 clinical trial results for donanemab, the antibody drug designed to target and clear the amyloid plaques considered key to progression of Alzheimer’s disease, reveal the drug’s “profound” clinical effect. 

Read more